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OBJECTIVE — Toquantifythemagnitudeandpatternofcognitivedifﬁcultiesinpediatric
type 1 diabetes as well as the effects associated with earlier disease onset and severe hypo-
glycemia.
RESEARCH DESIGN AND METHODS — Pediatric studies of cognitive function since
1985 were identiﬁed for study inclusion using MEDLINE and PsycInfo. Effect size (ES, Cohen’s
d) between the diabetic and control groups, expressed in SD units, were calculated within
cognitive domains to standardize meta-analysis test performance.
RESULTS — The meta-analysis sample of 2,144 children consisted of 1,393 study subjects
with type 1 diabetes and 751 control subjects from 19 studies. Overall, type 1 diabetes was
associated with slightly lower overall cognition (ES 0.13), with small differences compared
with control subjects across a broad range of domains, excluding learning and memory, which
were similar for both groups. Learning and memory skills, both verbal and visual (0.28 and
0.25),weremoreaffectedforchildrenwithearly-onsetdiabetes(EOD)thanlate-onsetdiabetes
(LOD), along with attention/executive function skills (0.27). Compared with nondiabetic
control subjects, EOD effects were larger, up to one-half SD lower, particularly for learning and
memory (0.49). Generally, seizures were associated with a negligible overall cognition ES of
0.06,withslightandinconsistentcognitiveeffectsfoundonsomemeasures,possiblyreﬂecting
the opposing effects of poorer versus better metabolic control.
CONCLUSIONS — Pediatric diabetes generally relates to mildly lower cognitive scores
across most cognitive domains. Cognitive effects are most pronounced and pervasive for EOD,
with moderately lower performance compared with control subjects. Seizures are generally
related to nominal, inconsistent performance differences.
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T
ype 1 diabetes affects 1i n5 0 0
children.Growingconsensusindi-
cates that children with type 1 di-
abetes, compared with control subjects,
are at risk of developing cognitive difﬁ-
culties (1). However, research results
are inconsistent regarding the magni-
tudeandpatternofcognitivedifﬁculties
due to heterogeneous samples, sam-
pling procedures, cognitive abilities as-
sessed, and study designs (1,2). Debate
remains over the extent and type of pe-
diatric diabetes cognitive difﬁculties—
general cognitive or speciﬁc neuro-
psychological—and their associated risk
factors.
Using meta-analysis to synthesize
dataacrossstudies,thisarticleaimstode-
termine whether there is evidence of cog-
nitive dysfunction in children with type 1
diabetes compared with demographically
similar children without diabetes. Exam-
ination of effect size (ES, Cohen’s d) high-
lights differences across various cognitive
domains and the magnitude of those dif-
ferences. A second aim of the current
study is to determine whether some chil-
drenwithtype1diabeteshaveanelevated
risk of cognitive dysfunction. Earlier age
of diabetes onset is identiﬁed in the liter-
ature as one of the strongest risk factors
associated with disrupted cognitive func-
tioning (3,4,5,6). To examine the impact
of early-onset diabetes (EOD) on cogni-
tive abilities, a second meta-analysis is
conducted to compare children classiﬁed
by authors as having earlier age at onset,
which may range anywhere from 4 to 7
years depending on the author, to later
age at onset (late-onset diabetes [LOD]).
Examination of ES determines the scope
and magnitude of differences, if any,
across cognitive domains. After the rela-
tive comparison of EOD and LOD, each
group is compared separately with chil-
dren without diabetes to better assess the
true magnitude of cognitive effects for
eachgroupcomparedwithchildrenwith-
out a chronic disease.
A clear picture of EOD effects is ob-
scured because EOD may be a surrogate
forrecurrentseverehypoglycemia;young
children with diabetes have a greater risk
ofseverehypoglycemia(7).LikeEOD,se-
vere hypoglycemia is also associated with
poorer performance on measures of cog-
nitive function, particularly memory (8),
although these ﬁndings have not been
consistent across studies (9,10). There-
fore, ancillary analyses will be conducted
to further explore the possible effects of
severe hypoglycemia on cognitive func-
tion. Finally, EOD may be a surrogate for
longer disease duration, since children
with earlier onset correspondingly have
longerdiseasedurationthanage-matched
children diagnosed later. However, there
are a limited number of studies available
that speciﬁcally examine the impact of
disease duration on cognitive function,
suchthattheseeffectsarenotexaminedin
the present study.
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METHODS
Study selection
MEDLINE and PsycInfo databases (from
1985through2008)wereusedtoidentify
cognitive performance studies in 1) chil-
dren with type 1 diabetes versus control
children without diabetes and 2) in chil-
drenwithtype1diabetesdividedintodis-
ease risk groups of a) EOD versus LOD
and b) seizures versus without seizures.
Key words used to search the literature
were: cognition, attention, memory,
learning, executive function, neurocogni-
tive, neuropsychological, and intelli-
gence. These descriptors were combined
with the terms diabetes, type 1 diabetes,
insulin-dependentdiabetesmellitus,chil-
dren, youth, and adolescents for the liter-
ature search.
Inclusion criteria
Studies in the overall meta-analytic re-
view fulﬁlled the following criteria: 1) re-
sults published or available in English
between 1985 and 2008, 2) children un-
der 18 years of age when diagnosed with
type 1 diabetes, 3) at least one measure of
cognitive performance, 4) original data
reportedwithsufﬁcientinformationtoal-
low calculation of ES (i.e., group means,
SDs, etc.), and 5) a deﬁned control group
matched for at least age. A total of 1,029
children with type 1 diabetes and 751
nondiabetic control subjects from 15
studies were evaluated for the overall di-
abetes versus control comparisons
(3,5,6,8,11–21) (online appendix Table
1, available at http://dx.doi.org/10.2337/
dc07-2132).
Additional studies that met the above
criteria and evaluated disease subgroups
for age of diabetes onset or seizures were
part of subgroup analyses (3–6,8–
10,12,18–22). In the onset analysis, 768
children with diabetes from seven studies
were divided into an EOD group (n 
232) or an LOD group (n  536), based
on each authors’ criteria. Seizure sub-
groups were comprised of 900 children
with diabetes from nine studies with 310
in a seizure group and 590 in a no seizure
group.
Before calculation of ES, results from
eachdomainineachstudywerestandard-
ized. Means and pooled SDs were used to
calculate Cohen’s d as the ES for the dia-
betes and control groups. One study pre-
sented data as least-squared adjusted
means (6), and raw data were obtained
and recalculated to ﬁt the meta-analysis
format.Threeotherpublishedstudiesuti-
lized test scores that could not be stan-
dardized and were therefore excluded (J.
Hagan, personal communication). Sev-
eral authors (including Hershey, Holmes,
Northam,Rovet,andRyan)reportedsim-
ilar data from the same subjects in multi-
ple publications; in each instance, data
from the latest longitudinal report or the
largest dataset were included.
Cognitive domains
Tasks from individual studies were as-
signed to one of six broad cognitive do-
mains based on classiﬁcation from
current neuropsychological texts (23), as
follows: intelligence, learning and mem-
ory, psychomotor activity and speed of
information processing, attention/
executive function, academic achieve-
ment, and visual motor integration. For
more speciﬁc analyses, these domains are
further divided into subcategories: Intel-
ligence is subdivided into crystallized
intelligence measuring acquired knowl-
edge and ﬂuid intelligence, which as-
sessesaperson’sabilitytousestrategiesto
apply unfamiliar information to new situ-
ations. The learning and memory domain
is divided into verbal and visual modali-
ties, i.e., verbal or visual learning and
memory. Because of the focus on these
skills in the pediatric literature and in the
classroom(12),thelatterisfurthersubdi-
vided into components of verbal or visual
learning (acquisition and storage of new
modality-speciﬁc information with re-
peated exposure) and verbal or visual
memory (immediate memory for new
modality-speciﬁc information). Psy-
chomotor activity and speed of informa-
tion processing contains the following
categories: psychomotor efﬁciency and
motor speed. Psychomotor efﬁciency in-
cludes cognitively demanding informa-
tion processing tasks and processing
speed (i.e., Symbol Search), and motor
speed includes measures of ﬁne motor
speed (i.e., Grooved Pegboard). All tasks
in these two subcategories are timed, and
performance is measured based on how
many items are completed correctly. The
attention/executivefunctiondomaincon-
sists of simple and complex attentional
tasks, abstract problem solving, and deci-
sion making. Academic achievement en-
compasses academic skill development
across broad areas of classroom perfor-
mance including math and reading. Vi-
sual motor integration measures ability to
coordinate visual perceptual input with
ﬁne motor output where performance is
based on the quality of the written output
and is not timed (e.g., Beery-Buktenica’s
DevelopmentalTestofVisual-MotorInte-
gration).Tasksthatcouldnotbeclassiﬁed
were not included.
Statistical analyses
Cohen’s d was calculated as a measure of
ES (24). ES, which represents the stan-
dardized differences between diabetic
andcontrolgroupsexpressedinSDunits,
was calculated for each cognitive domain
in each study. The direction of an ES in-
dicates better or poorer cognitive perfor-
mance. In the meta-analysis, a combined
d value is reported for each cognitive do-
mainasanexpressionofthemagnitudeof
associations across studies. The d values
are weighted for sample size to adjust for
possible bias due to unequal samples
across studies. The number of partici-
pants that contributed data to each ES is
noted in parentheses in Fig. 1A and B.I n
addition, the 95% CI, on the basis of the
SE, provides an indication of the signiﬁ-
canceofthedifferenceinperformancebe-
tween the diabetic and control groups.
An overall d value, in which all cogni-
tive domains are pooled, was computed
ﬁrst as an index of general cognitive func-
tion (overall cognition). To address the
possibilityofpublicationbias,afail-safeN
also was calculated. This measure is used
to estimate the number of unpublished
nonsigniﬁcant cognitive domains neces-
sary to falsify the signiﬁcant overall cog-
nitionES.InFig.1A,thefail-safeNis187.
For the overall cognition ES to be nonsig-
niﬁcant, an additional 187 nonsigniﬁcant
cognitive domains would be necessary,
suggesting that observed signiﬁcant ef-
fectsarenotlikelyduetopublicationbias.
Statistical overview
Meta-analyses were performed separately
for the difference between the diabetic
and control groups and for the possible
contribution of disease factors, such as
age of diabetes onset to performance. The
Comprehensive Meta-Analysis (CMA,
version 2) statistical package (25) was
used for all analyses and to create forest
plots.
Subgroup meta-analyses
Subgroup meta-analyses examined the
relative contribution of the following dis-
easeriskfactorstoperformanceineachof
the cognitive domains reported in Fig. 1.
EOD versus LOD. EOD was deﬁned by
the authors of the original studies and in-
cluded subjects diagnosed before 4 years
of age (5,6), 5 years of age (3,18,19,22),
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this meta-analysis, performance of chil-
dren with EOD was deﬁned inclusively as
younger than age 7 years (n  232) and
wascomparedwiththosewithlateronset,
LOD (n  536).
EODandLODversuscontrol. Asubset
of ﬁve onset studies with matched nondi-
abetic control subjects was evaluated in
twosupplementalmeta-analysestodeter-
minerepresentativecognitiveproﬁlesand
the relative magnitude of ES for children
with EOD (n  166) and LOD (n  322)
in comparison with healthy control chil-
dren (n  414) (3,5,6,18,19).
Severe hypoglycemia. Severe hypogly-
cemia was deﬁned by Epidemiology of
Diabetes Interventions and Complica-
tions criterion (26) of at least one sei-
zure (n  310 vs. no seizures, n  590).
Two studies (9,21) categorized hypo-
glycemic episodes as severe if patients
required glucagon or the assistance of
others, consistent with the earlier Dia-
betes Control and Complications Trial
deﬁnition (27).
RESULTS—Altogether 15 studies of
pediatric diabetes and cognitive function
were identiﬁed in the literature that met
criteria for inclusion in the meta-analysis
shown in Fig. 1A. The overall diabetes/
controlmeta-analysissample(N1,780)
consisted of 1,029 children with diabetes
(mean age 12.96 years) and 751 control
subjects (mean age 12.55 years). Most
studies matched subjects according to
participant age. Seven studies matched
participants according to parents’ educa-
tion, occupation, or both, usually by use
of sibling control subjects. The average
age of diabetes onset was 6.6 years (range
4.13–11.8), and the average diabetes du-
ration was 5.23 years (0.5–8.9).
Childrenwithtype1diabetesdemon-
strated slightly lower performance than
control subjects (overall cognition
0.13) in all cognitive domains, except
learning and memory. Lower scores were
found in intelligence (crystallized and
ﬂuid), psychomotor activity and speed of
information processing (psychomotor ef-
ﬁciency and motor speed), attention/
executive function, visual motor
integration, and academic achievement.
Most ES’s are small (d  0.2) according
to Cohen’s criteria (24). The ES translates
into slightly lower group test scores of
1–3 standard score points that are not
likely to be clinically detectable (standard
score mean  SD: 100  15). The cogni-
tive performance of both groups is gener-
ally age appropriate, consistent with
previous reports (3,11) (Fig. 1A).
Subgroup meta-analyses
AllcognitivedomainslistedinFig.1were
evaluated for each of the subgroup com-
parisons (onset and seizure). Average age
of diabetes onset for the subgroup analy-
ses is 6.3 years (range 4.1–8.6) with a
meandiabetesdurationof5.9years(2.6–
8.9). Children in the subgroup analyses
were approximately the same age (mean
12.59 years) as those in the overall sam-
ple, had the same average age of diabetes
onset (mean 6.3 years), and slightly
longer diabetes duration (5.9 vs. 5.2
years, respectively).
Earlier onset of diabetes: EOD versus
LOD. Fig.1,PanelB,showsthatchildren
with EOD performed more poorly than
LOD children in Overall Cognition, ES of
0.20. In contrast to the overall diabetes
effect of intact learning and memory in
Panel A of Fig. 1, EOD is associated with
strongest effects in lower Verbal (0.28)
and Visual (0.25) Learning and Mem-
ory, Attention/executive function
(0.27),Academicachievement(0.19)
and lower Crystallized Intelligence
(0.15). A trend toward lower Fluid In-
Figure1—StandardizedES—PanelA.DiabetesversusControlchildrenmeta-analyticstandard-
ized ES (Cohen’s d) for the cognitive domains. Number of participants included in the calculation
of each domain is listed in parentheses. Refs.: Overall Cognition  (3,5,6,8,11–21), Crystallized
Intelligence  (3,5,6,11,12,14,16,17,19–21), Fluid Intelligence  (3,5,6,11,12,14,16,17,19–
21), Verbal learning and memory  (3,6,8,12,15,19–21), Visual learning and memory 
(3,6,8,12,19–21), Psychomotor Efﬁciency  (6,11,12,14,16,19,20), Motor Speed  (3,8,11–
13,16,19,20), Attention/Executive Function  (3,6,8,11–14,16,17,19,20), Academic Achieve-
ment  (3,5,11,12,16,18,19), Visual Motor Integration  (5,11,12,19,20) —Panel B. Earlier
versus Later Disease Onset group meta-analytic standardized ES (Cohen’s d) for the cognitive
domains. Number of participants included in the calculation of each domain is listed in parenthe-
ses. Refs.: Overall Cognition  (3–6,8–10,12,18–22), Crystallized Intelligence 
(3–6,9,10,19–22), Fluid Intelligence  (3–6,9,10,19–22), Verbal learning and memory  (3,6,8–
10,12,19–22), Visual learning and memory  (3,6,8–10,19–22), Psychomotor Efﬁciency 
(6,10,19,20,22), Motor Speed  (3,8,19,20,22), Attention/Executive Function  (3,6,8–
10,19,20,22), Academic Achievement  (3,5,18,19,22), Visual Motor Integration  (5,19,20).
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early onset are larger than those for the
overall diabetes versus control meta-
analysis, but still within the small range,
according to Cohen’s criteria (24). (Panel
B, Fig. 1)
Earlier onset of diabetes: EOD and
LOD versus control. To better deter-
minethepatternandmagnitudeofcogni-
tive proﬁles associated with EOD and
LOD subgroups, a comparison between
each onset group and nondiabetic con-
trols was undertaken. Two additional
MA’swereconductedwithasubsetofﬁve
studies that contained onset groups and
nondiabeticcontrols(3,5,6,18,19).Com-
parable LOD  Control performance
could suggest that the overall diabetes
ES’s in Panel A of the ﬁgure are a function
of lower EOD scores that skew the diabe-
tes scores. Due to the tests available for
these analyses, it was not possible to sub-
divide the Learning and Memory catego-
ries beyond modality effects.
EODversuscontrol. Whenthescoresof
EOD children are compared to nondia-
betic controls instead of the LOD disease
contrastgroup,notsurprisingly,themag-
nitude of the ES’s are larger (i.e., Overall
Cognition  29). Most striking are in-
dividual ES’s for lower EOD Verbal
(0.49) and Visual (0.44) Learning
and Memory, poorer Attention/Executive
Function (0.39), and lower Intelligence
as reﬂected by both Crystallized (0.35)
andFluid(0.28)abilities.TheseES’sare
moderate in magnitude and range up to
6.5tosevenpointsloweronstandardized
tests, which may be clinically meaningful
and detectable in a classroom setting.
Only two domain ES’s failed to reach sig-
niﬁcance: Psychomotor Efﬁciency
(0.37) and Visual Motor Integration
(0.16) although they trended lower as
well. Test variability in the measures uti-
lized appears to account for failure of the
moderately-sized Psychomotor Efﬁciency
effect to reach signiﬁcance. In sum, while
many cognitive effects are present, learn-
ingandmemoryabilities,bothverbaland
visual, are the most negatively impacted
in this subgroup of children.
LOD versus control. While the magni-
tude of the difference is not as large, LOD
performance was also lower than that of
nondiabeticcontrolsinOverallCognition
(0.13). In fact, the magnitude of the
LOD difference is consistent with the
Overall Cognition ES for the Diabetes
group in Fig. 1, Panel A, suggesting that
general diabetes results in Panel A are not
skewed by including EOD effects. Small
LOD effects were found in both lower
Crystallized (0.20) and Fluid (0.14)
Intelligence,VisualLearningandMemory
(0.17), Motor Speed (0.17) and Vi-
sual Motor Integration (0.17), but not
Verbal Learning and Memory (0.03),
Psychomotor efﬁciency (0.04) or Aca-
demic achievement (0.01).
Hypoglycemic seizures (SZ). Sei-
zures are associated with a nominal Over-
all Cognition ES of 0.06 and small to
nominally lower scores in four cognitive
domains of Crystallized (0.19) and
Fluid Intelligence (0.21), Academic
achievement (0.10) and Visual motor
integration (0.06). In contrast, nomi-
nally better visual memory (0.13) and
learning (0.12) is present. Generally, sei-
zuresareassociatedwithnominalorsmall
cognitive effects that are inconsistent and
should have little clinical impact for chil-
dren with type 1 diabetes as a whole, al-
though some individual children may be
more adversely affected.
CONCLUSIONS—Children with
TIDperformedslightlylesswellthancon-
trols on global measures of intelligence
and on a broad range of speciﬁc neuro-
psychological skills such as attention/
executive function, providing support for
a relation between type 1 diabetes and
slightly lower cognitive function. Score
differences are found in all broad cogni-
tive domains except learning and mem-
ory. The ES of 0.13 for Overall
Cognition, however, converts into nomi-
nal score differences that are one to two
points lower on average for children with
diabetes versus controls. See Fig. 1, Panel
A. A small difference of this magnitude is
not clinically signiﬁcant and indicates
that overall group cognitive performance
is generally intact and age appropriate.
However, despite generally intact group
scores, there is likely to be some variabil-
ity in cognitive abilities across individual
children that could range from some sub-
tly affected individuals with circum-
scribed effects to others who may have
moderate or even severe dysfunction.
Furtherassessmentofvariousdiseaserisk
factors and their associated cognitive ef-
fects may lead to better identiﬁcation of
those children most at-risk for more se-
vere disruption.
The secondary analyses in this study
identiﬁes subgroups of children most at-
risk for cognitive disruption. Findings in-
dicate that children with earlier diabetes
onset (EOD), before the age of 7, show
evidence of greatest cognitive disruption,
with an Overall Cognition ES of-0.20 or
3-points lower performance across multi-
ple domains, compared to their disease
contrast group with later onset (LOD).
SeeFig.1,PanelB.Contrarytotheoverall
Diabetes meta-analysis with no learning
and memory effects, the EOD children
show their largest ES’s in both lower ver-
bal and visual learning and memory, con-
gruent with literature ﬁndings reported
for both seizures and EOD (1,2,17). Other
EOD effects include small differences in at-
tention/executive function and lower
crystallized intelligence (i.e., acquired in-
formation), but not ﬂuid intelligence (vi-
sual/spatial) scores. Academic
achievement also is slightly lower for
EOD compared to LOD children. Gener-
ally, all of these effects are small, in the
range of a quarter of a standard deviation.
EOD and LOD versus control
comparisons
To determine cognitive proﬁles uniquely
associated with each onset group and to
test the possibility that EOD effects might
underliethegeneraldiabeteseffectsinthe
overall meta-analysis (Fig. 1, Panel A), a
subset of EOD and LOD children with
matched controls was evaluated with fur-
ther meta-analyses (3,5,6,18,19). When
compared to nondiabetic controls, the
EOD group displays a larger difference in
lower overall cognition (0.29) then
compared to the LOD disease contrast
group (0.20). Healthy children without
a chronic disease are the typical compar-
ison group in a classroom setting, and
EOD children show moderate ES’s, al-
most
1/2 standard deviation lower, in cru-
cial verbal (0.49) and visual (0.44)
learning and memory skills. This ES
translates into 6.5 to 7-point lower scores
and may be detectable in a learning envi-
ronment. Moderately lower attention and
executive function (0.39), a diverse set
of higher order cognitive processes, such
as planning, inhibitory control, and sus-
tainedattention,isalsofoundintheEOD/
Control comparison. Poorer attention
andexecutivefunctionabilitieshavebeen
identiﬁed in children with learning dis-
abilities and may impact learning in the
classroom. A 6-point difference in selec-
tive deployment of attention and deci-
sion-making, skills required to learn
salient information in academic settings,
also might be detectable in a learning en-
vironment. Lower academic achievement
is found (ES  0.28) along with lower
crystallized and ﬂuid intelligence, which
in toto indicate widespread and generally
Gaudieri and Associates
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with EOD youth compared to controls,
with particularly negative effects for
memory and learning.
Results also show that the scores of
LOD children are lower than nondiabetic
controlsand,infact,theLODoverallcog-
nition ES of 0.13 mirrors that of the
general diabetes/control difference in Fig.
1, Panel A. Children with LOD exhibited
lower crystallized and ﬂuid intelligence,
as well as intact verbal but lower visual
learning and memory. Lower visual mo-
tor integration skills also are found along
with reduced psychomotor speed. In
sum, it appears that children with later
diseaseonsetexperienceslightbutdetect-
able performance differences when com-
pared to controls. However, effects are
small, in the order of one to three points
on standardized tests, which suggest that
as a group, these ﬁndings are not clini-
cally meaningful. However, as with the
diabetes/control comparisons, there is
likely to be variability across children,
with some demonstrating no impairment
and some demonstrating moderate to se-
vere difﬁculties.
Seizures (SZ) were related to the
smallestOverallCognitionESof0.06of
all groups evaluated; a negligible (@-1
point) difference on average. Neverthe-
less, larger effects, although still small,
were found in Crystallized and Fluid In-
telligence (@-3 points) as well as nomi-
nally lower scores in visual motor
integrationandacademicachievement(@
1point).Incontrast,bettervisualmem-
ory and learning (@ 1.3 points) was
found. This discrepancy in performance
may be due to the opposing effects of
those in relatively poorer versus better
metabolic control, effects that cannot be
measured in these analyses. Negligible or
generally absent cognitive difﬁculties is
congruent with results from a number of
cross sectional studies (9,10) and the lon-
gitudinal DCCT and EDIC studies
(26,27) but varies with some individual
reports (8,21). While results of this MA
suggest that hypoglycemic seizures ap-
peartoberelativelyinnocuousintermsof
overall pediatric cognitive effects, with an
average diabetes duration of 5.23 years,
effects may be greater for children in
chronicallypoorermetaboliccontrolwho
have been shown to have lower scores in
individual studies (5,26,27). Further, the
present meta-analysis ﬁndings cannot
rule out a synergistic effect when seizures
occurinchildrenwithearlierdiabeteson-
set (28) who may be more adversely
affected.
Frequently, EOD children have a sig-
niﬁcant number of seizures due to the be-
havioralandmedicalchallengesofdisease
management in children younger than
age seven (5). This confound between
EODandseizuresissuchthatatonepoint
in the pediatric literature, EOD was hy-
pothesized to be a proxy or masking vari-
able for the presumed underlying effects
of seizures (7). The present MA results,
based on a large number of over 2,000
pediatric patients from many different re-
search groups, suggest that the effects of
seizures may be more benign than origi-
nallyhypothesizedformostchildren,and
equally importantly, seizures do not ap-
peartobeaproxyorsurrogatevariablefor
EOD. Interactive effects may ultimately
prove more likely (6,21).
Could the pervasive cognitive effects
ofEODinthepresentmeta-analysisresult
from method insensitivity to detect EOD
differential or circumscribed effects?
Probablynot,becausethemeta-analysisis
able to detect very circumscribed and
small, even negligible, effects associated
with hypoglycemic seizures. An impor-
tant consideration though is that the ad-
ditional EOD results are based in part on
some of the earliest studies in the litera-
ture (3,5) although more recent studies
reveal consistent ﬁndings (19), including
a large-scale post-DCCT longitudinal
study (6). Now, the next questions may
be what mechanisms place EOD children
at increased risk and what prevention
stepsarepossible?WhileEODstatusitself
cannotpresentlybealtered,itspotentially
negative interactions with other disease
risk variables such as hypoglycemic sei-
zures and chronic hyperglycemia can be
minimized. EOD may produce a back-
ground vulnerability (28) that might am-
plify the negative effects of these other
disease risks. Undesirable glucose excur-
sions may be minimized with continuous
glucose monitoring systems that warn
of glucose perturbations to help achieve
near-normal metabolic control.
While the present authors were un-
able to assess the impact of diabetes du-
ration on cognitive function due to a lack
of relevant studies, it is noteworthy that
small, but reliable cognitive differences
are documented in this meta-analysis of
children who have an average disease du-
rationofjust5.23years.Cognitiveeffects,
although mild, appear relatively quickly
following diagnosis. Consistent with this
appraisal, Northam et al. ’s longitudinal
evaluation of 90 newly diagnosed chil-
dren also revealed cognitive changes over
just a 6-year period (6). After only two
years children with diabetes, particularly
those with EOD (4years), exhibited less
improvement on measures of nonverbal
visuospatialskillsthanthosewithLODor
controls (6). Taken together, the impact
of diabetes upon pediatric cognition ap-
pears to begin shortly after diagnosis. Fu-
turestudiesshouldexaminetheimpactof
disease duration on cognition and iden-
tify if possible CNS or other biological
changes may occur over time.
Limitations
This meta-analytic documentation of a
conclusive, but small, relation between
TID and cognitive function in a large pe-
diatric sample is signiﬁcant given the
“noise” and variability present in most
clinical research studies. However, many
of the factors that contribute to variability
among studies should be considered in
the interpretation of the present results.
First and foremost, many of the studies
includedinthismeta-analysiswerecross-
sectional in nature. Derivation of causal
inferences is problematic. More rigorous,
longitudinal studies with glucose meters
or continuous glucose monitoring sys-
tems to track glucose excursions may bet-
ter examine the locus and progression of
cognitive difﬁculties over time, particu-
larly when coupled with neuroimaging
studies. Secondly, the pattern of sub-
group results appears to clearly implicate
early disease onset with the greatest mag-
nitude and scope of cognitive difﬁculties
compared to controls. However, disease
subgroup differences should be inter-
preted with caution since they are not in-
dependent effects. Future studies may
ﬁnd that it is the interaction among dif-
ferent disease variables that most strongly
impacts cognition in children.
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